Newsletter Subject

[Premium Alert] for Thursday 2/2 - My #1 low-priced BioLife Sciences stock (Name & Symbol)

From

10xprotrader.com

Email Address

newsletter@10xprotrader.com

Sent On

Wed, Feb 1, 2023 09:06 PM

Email Preheader Text

Breakout Alert: Wednesday February 1, 2023 New Premium Alert for Thursday BioLife Sciences Inc. Red

Breakout Alert: Wednesday February 1, 2023 New Premium Alert for Thursday BioLife Sciences Inc. (BLFE) Red Hot Early-Stage Biotech Company with 100% Upside Potential? Hi 10XMember, This is Kevin Vander with “10XProTrader” delivering you your new premium alert for Thursday 2/2 - trading session is BioLife Sciences Inc. (BLFE) COVID-19 vaccines, cancer immunotherapies, glucose monitors, and pacemakers -- what do these have in common? All were developed by "life sciences" companies, many of which have achieved tremendous scientific breakthroughs. Life sciences companies also have made many shareholders wealthy along the way. Leading me to share with you an incredible low-priced stock with enormous upside potential. The timing couldn't get any better for you than right now! BioLife Sciences Inc. (BLFE) specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products and disruptive technology. One of BioLife Sciences’ core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies. Over the course of the last two years, BLFE has gone through a number of company changes evolving into a revamped corporate entity focused on disrupting various consumer verticals, with a specific focus on being the #1 Disruptor in the health and wellness sector. BioLife Sciences, Inc. just released Game-Changing news on 1/18/23 that could trigger buying momentum sending shares potentially much higher in price. BioLife Sciences Inc. (BLFE) Copper-Infused Fabric Pots Offer Investors Oppor∙tunity In $2.4 Billion US Home & Garden Market! BioLife Science Inc. (BLFE) is offering investors an oppor∙tunity in the soaring $2.4 billion US home gardening market. It has set a Q1 release of a prototype of its high-technology copper-infused fabric growing pot. Investors might consider BioLife as a high-tech company seeking to disrupt growth industries. It spent more than one year developing the copper-infused fabric pot as an alternative in the fast-growing multi-bill∙ion do∙llar home gardening industry. The prototype pot is environmentally sustainable. (BLFE) offers multiple revenue streams. It is also strengthening its positioning in the cannabis sector. Last year, (BLFE) launched its first line of cannabinoid consumer products. This is a high-technology company worth watching for its innovation in quick-growth industries. BioLife Sciences, Inc. Primed For Growth! BioLife Sciences is Born: In June of 2020, the OTC Markets public entity formerly known as Rhino Novi Inc. (RNOV) underwent a reverse merger transaction – changing its name and ticker symbol to BioLife Sciences Inc. (BLFE). While Rhino Novi originally focused on VOIP products, the newly formed BioLife would focus on developing and marketing disruptive technologies to a variety of consumer verticals. Harnessing the Antimicrobial Power of Copper? BioLife has reported it focused on the utilization of the natural antimicrobial power of copper and harnessing its innate benefits into everyday textiles. This dynamic elemental metal has a wide variety of beneficial traits, including being required by all plants and animals as a key mineral and nutrient necessary for survival. BioLife says it has focused its attention on incorporating the power of copper into everyday products which are fabric-based and disruptive, in contrast to the market’s current offering. Some of these products in development include copper-infused fabric gardening pots, copper-infused gardening gloves, copper-infused microfiber towels and copper-infused air filters. What is MFusion? The company states that traditional copper-infused products that consumers will find on the market today provide limited-to-partial copper coverage. This means that there could are often gaps in the copper coverage, resulting in less-than-optimal results. BioLife addresses this problem with the introduction of their unique copper infusion process: MFusion. MFusion infuses copper into every sub-bundle of the fabric, providing more complete coverage. When copper is infused into textiles via MFusion, the resulting fabrics benefit from 100% evenly distributed copper coverage. MFusion can be applied to any textile – from t-shirts to air filters – with the result being total copper infusion. The 2022 Acquisition of Health Box LLC – What’s Next? In February of 2022, BioLife completed the acquisition of Health Box LLC – an Arizona-based orthomolecular medicine and natural health products company. By completing this acquisition - and appointing Nika Jaksic, Health Box’s founder, as the new COO, the company believes it has positioned itself to enter the orthomolecular and natural health products space. In order to facilitate the Company’s aggressive expansion plans, the Company filed for a Regulation A+ Tier 1 Offering. The SEC qualified BioLife and the Company is eligible to raise up to $20 million. BioLife Sciences, Inc. The Full Report Below BioLife Sciences Inc. (BLFE) is a commercialization accelerator of innovative and disruptive technologies for the healthcare, beauty and food & beverage industry sectors. One of BioLife Science’s core building block strategies is to develop, partner and assist innovative companies with commercialization of leading-edge technologies. [Follow This Link for a Report]( About BioLife Sciences Inc. Bio Life Sciences Corp. develops, licenses, and distributes antibacterial products and non-contact human temperature screening technology. It offers disinfecting wipes, UV sterilization technology, electrostatic disinfection services, anti-microbial textiles, and touchless vending/marketplaces products. Bio Life Sciences Corp. was incorporated in 2018 and is based in Mississauga, Canada. [Company Website here]( BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products and disruptive technology. One of BioLife Sciences' core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies. On August 2nd, 2022 BioLife Sciences Inc. was interviewed by SmallCapVoice. During the interview the COO "Nika Jaksic" provided very impressive future shareholder growth topics. BioLife Sciences Inc. Interview With SmallCapVoice Provides Very Encouraging Future Shareholder Value [Follow This Link Here For Audio Version]( The interview includes discussion on BioLife’s plans for uplitsing and its upcoming launch of an innovative product to improve cannabis cultivation. BioLife is a commercialization accelerator focused on moving innovative products from the lab to small scale production while also conceptualizing and innovating its own line of products. Speaking with SCV’s Stuart Smith, Jaksic explains how the Company’s wide approach to this model creates unrestrictive market oppor∙tunity. “We like to take disruptive ideas and grow and expand those ideas into marketable products that aim to enrich the lives of our customers and our communities, whether that’s a new concept being developed from scratch, or simply us reinventing the wheel,” he says. “We’re not going to limit ourselves to any one product or any one industry. If we have a marketable idea that will help our customers and benefit our shareholders, then we will pursue.” Jaksic next describes how a corporate transformation, brought-on by a leadership change in 2020, has enhanced business development. This growth includes an acquisition strategy that enables the introduction of new and innovative products to the market. As the Company advances on these oppor∙tunities, it is now prepared to broaden its exposure to the investment community. “Uplisting to the OTCQB has traditionally resulted in greater liquidity, increased transparency, upgraded reporting standards, better overall awareness of the company to our larger group of investors, including venture capitalists,” he says. “Aside from that, we are going to continue developing our new natural health products division so we can keep expanding our company and its offerings in the coming years. And of course, we’re going to introduce new and exciting products to the marketplace so we can increase the Company’s revenue. We’re excited about what the future holds for our Company and its shareholders.” A high-potential aspect of BioLife’s future pivots from its acquisition of Health Box LLC, a health products company founded by Jaksic in 2020, along with a new focus on copper-infused textiles. “When I say we ‘reinvent the wheel,’ that is exactly what we accomplished with our copper infusion process and the resulting line of product,” Jaksic says, explaining how the COVID-19 pandemic generated greater demand for products utilizing copper’s antimicrobial properties. While there are many copper-infused textiles in the market, BioLife distanced itself from competitors by offering superior and innovative copper-infused textiles. The root innovation is the Company’s unique copper infusion process, which significantly improves copper distribution throughout the fibers of the fabric while reducing costs and time. “We can use infusion in the traditional way to design our copper-infused garments from scratch … or we can do it by obtaining preexisting garments and infusing them with copper after they have been designed,” Jaksic says. This capability enables BioLife to pursue partnerships with other companies that want to improve the quality and efficacy of their products beyond industry standards. Based on this technology, the Company intends to initiate three novel product launches within the next year, starting with an antimicrobial copper-infused fabric gardening pot. This product launch will position the Company before a new market of customers in the $300+ Billion global can∙nabis cultivation market. “The copper works as a fungicide that eliminates harmful microbes while simultaneously boosting the beneficial organisms that thrive in the soil. The results are healthier and stronger plants with larger yields as well as healthier soil,” Jaksic explains. “Our main target demographic will be cannabis cultivators due to the unique growing requirements of cannabis. Cannabis farmers are keenly aware of the benefits of fabric pots. We will vigorously pursue the cannabis cultivator market, but we will additionally focus on farmers, agricultural professionals, home gardeners, landscapers, nurseries and some industrial gardening organizations.” BioLife Sciences Inc. Has "7" Key Catalysts That Provide A Bullish Outlook! - Catalyst #1: BioLife Sciences Inc.’s (BLFE) Copper-Infused Fabric Pots Offer Investors Oppor∙tunity In $2.4 Billion US Home & Garden Market. - Catalyst #2: BioLife Sciences Inc. (BLFE) is Pleased to Announce Its Q1 2023 Slated Release of Its Copper-Infused Fabric Pot Prototype. - Catalyst #3: BioLife Sciences Inc. Seeks to Retain an Auditing and Consulting Services Firm. - Catalyst #4: Early-Stage Investment Oppo∙rtunity - Recent Reg A+ Offering Announced July 15th, 2020 ($20,000,000 for Growth Expansion) - Catalyst #5: BioLife Sciences Retains Benzinga for Marketing Campaign. (2,000,000+ investors trust Benzinga for investment ideas). - Catalyst #6: BioLife Sciences Retains GS Whitney & Co for Corporate Relations. (Top Wall Street Small-Cap Investor Relations Firm). - Catalyst #7: BioLife Sciences Announced on 7/11/2022 The Launch of BioLife Copper-Infused MicroFiber Towels. ($790 mill Sector by 2026). I am urging all of my members to add BLFE to the top of their watch list right now, and be ready at the opening bell Thursday morning! ...Stay on the lookout for my next update coming on BLFE. 10X Your Wealth, Kevin Vander Publisher, 10XProTrader.com Investment Research Leg∙al Entity Information: 10XProTrader is a website owned and operated by 10XPublishing, LLC., which is a DBA of 10XMedia, LLC. You are receiving this e-mail as part of your subscription to 10XProTrader. Please do not reply to this e-mail as this address is not monitored. Help line: Customer service number is 1-800-803-4811 Mailing Address: Attn: Member Services | 10XMedia, LLC. 340 Royal Poinciana Way Suite 317-#409 Palm Beach, FL 33480 Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET. © 2023 10XMedia, LLC. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular inves∙tment situation. N∙o communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. © 2023 10XProTrader.com, All Rights Reserved. 10XProTrader is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. This communication is a paid advertisement. 10XProTrader.coms is owned and operated by 10XMedia LLC, which is a Florida based Limited Liability Company and/or its subsidiaries and/or affiliates ("Company," "we," or "us") have been compensated $20,000 USD to disseminate this communication. To date we have been compensated a total ($80,000 USD) Eighty Thousand dollars USD cash. Please review the full disc∙laimer at [( for important information about this advertisement. © 2022 10XProTrader. All rights reserved., 340 Royal Poinciana Way Suite 317, 33480, Palm Beach, United States You may [unsubscribe]( or [change your contact details]( at any time.

Marketing emails from 10xprotrader.com

View More
Sent On

05/12/2024

Sent On

05/12/2024

Sent On

08/10/2024

Sent On

08/10/2024

Sent On

23/09/2024

Sent On

23/09/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.